Ose Immunotherapeutics : Documents made available to the shareholders for the combined general meeting of June 25th, 2025

About this update from Ose Immunotherapeutics Sa

[{"type":"image","alt":"OSE Immunotherapeutics","displaySize":"","headline":null,"caption":"OSE Immunotherapeutics","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":100,"url":"https://media.zenfs.com/en/globenewswire.com/bca4e9e3611afcc1a4e99230a01fa8eb"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/h55Oot7mWh39J7Yvj1GueA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE0MDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/bca4e9e3611afcc1a4e99230a01fa8eb","width":300,"height":100}},"lazy":false},{"type":"text","content":"Documents made available to the shareholders for the combined general meeting of June 25th, 2025","length":96,"tagName":"p"},{"type":"text","content":"Nantes, June 4th, 2025, 8 a.m. - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) announces the publication of the preparatory documents for the combined general meeting to be held on June 25th, 2025 at 10 a.m. at the Drawing House Hotel - 21, rue Vercingétorix - 75014 Paris.","length":286,"tagName":"p"},{"type":"text","content":"The convening notice (avis de reunion valant avis de convocation) containing the agenda and the resolutions, as well as the conditions for attending and voting at this General Meeting, was published in the BALO on May 21st, 2025 and the convening notice will be published in the BALO and in a legal gazette on June 6th, 2025.","length":325,"tagName":"p"},{"type":"text","content":"The preparatory documents required by Article R. 22-10-23 of the French Commercial Code are available on the Company's website: https://www.ose-immuno.com/assemblees-generales/.","length":181,"tagName":"p"},{"type":"text","content":"In accordance with the applicable regulations:","length":46,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Registered shareholders may, up to and including the fifth calendar day before the General Meeting, ask the Company to send them the documents referred to in Articles R.225-81 and R.225-83 of the French Commercial Code, where applicable at their express request by electronic means. For shareholders in bearer form, the exercise of this right is subject to the provision of a certificate of participation in the accounts in bearer form held by the authorized intermediary.","length":472,"tagName":"p"}]},{"val":[{"type":"text","content":"Any shareholder may consult the documents referred t...

More updates from Ose Immunotherapeutics Sa